Screener
National Research Corporation NRC Q2 2026 earnings
Reported July 28, 2026 · After market close
Revenue$35.4MBeat by $492.0K
EPS$0.31Beat by $0.46
Revenue estimate$34.9M
EPS estimate-$0.15
“As healthcare organizations increasingly seek partners who can help improve experience outcomes, strengthen governance, and build enduring brand value, we believe NRC Health is uniquely differentiated through our three connected strengths: delivering continuous consumer and patient insights, providing trusted partnership and strategic engagement with healthcare leaders, and enabling actions that lead to improved outcomes.”
Earnings data and commentary were extracted with AI from company filings and may contain errors. Verify important details in the filing.
Next report
Oct 26, 2026 (in 3 months)Revenue estimate$35.8M
EPS estimate$0.21
Financials
Q2 2026Valuation & ratios
Versus estimates
Revenue
Diluted EPS
FAQ
- When did National Research Corporation report Q2 2026 earnings?
- National Research Corporation (NRC) reported Q2 2026 earnings on July 28, 2026 after market close.
- What were National Research Corporation's Q2 2026 revenue and EPS?
- National Research Corporation reported revenue of $35.4M and eps of $0.31 for Q2 2026.
- Did National Research Corporation beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $34.9M by $492.0K. EPS beat the consensus estimate of $-0.15 by $0.46.
- How did National Research Corporation's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 4.0% from $34.0M a year earlier and eps grew 10.7% from $0.28.
- Where can I find National Research Corporation's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001437749-26-024663) and the 10-Q periodic report (0001437749-26-025624) directly on SEC EDGAR. The filing index links above go to sec.gov.
